Zomedica Pharmaceuticals (ZOM) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Zomedica Pharmaceuticals has appointed Scott A. Jordan as Executive Vice President, Finance and Chief Financial Officer, starting January 1, 2025. With over 30 years of experience in the life sciences and diagnostics industries, Jordan’s strategic finance and business development skills are expected to drive Zomedica’s growth in the animal health sector. His extensive background includes founding S. Jordan Associates and holding key financial roles in biotechnology companies.
For further insights into ZOM stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Disney (NYSE:DIS) Cuts Stephanopoulos Pay Post-Trump Settlement
- Ford (NYSE:F) Quality Turns In Surprising Win
- Intel (NASDAQ:INTC) Narrows Down Altera Buyers
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
